CellaVision reinforces management team with a Vice President of Sales & Business Development
CellaVision reinforces its management team with Ron Hagner as Vice President of Sales & Business Development, effective from today. Mr. Hagner, based in Chapel Hill, NC, USA, has the overall responsibility for CellaVision's global sales and business development since 2011.
Mr. Hagner has been an employee of CellaVision since 2001, where he was responsible for first establishing CellaVision's sales offices in the USA and Canada, among other things.
"I'm very pleased to have Ron as part of our management team. His blend of sales, marketing and medical laboratory knowledge has been a great asset to our organization over the years. Ron's key responsibilities are the identification and development of business partnerships that will aid CellaVision's future expansion and growth, and includes management of the start-up of our market office in China and our planned entry into the Veterinary market in North America," says Yvonne Mårtensson, CellaVision's CEO.
Ron Hagner holds a Master's degree in Medical Biology and has more than 30 years' experience with medical device companies. Prior to CellaVision, Ron was the Marketing Director for Bayer Diagnostics and the Vice President of Sales & Marketing for both Intelligent Medical Imaging (Palm Beach Gardens, FL) and Triangle Biomedical Sciences (Durham, NC).For further information, please contact:
Yvonne Mårtensson, CEO, CellaVision AB
Phone: +46 708 33 77 82. Email: firstname.lastname@example.org About CellaVision
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The analyses often constitute important reference data for fast and correct diagnosis of illnesses, for example of infections and serious cancers. CellaVision's products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. In 2011 sales were SEK 155 million and sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's registered office is in Lund and the company has subsidiaries in the USA, Canada and Japan. The share is listed on the Nasdaq, OMX Stockholm, Small Cap list. Read more at www.cellavision.com